Is Hydroxyurea Leukemogenic in Essential Thrombocythemia?
Open Access
- 15 August 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (4) , 1459-1461
- https://doi.org/10.1182/blood.v92.4.1459.spll5_1459_1461
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p DeletionBlood, 1998
- BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients: Clinical PresentationBlood, 1997
- Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and PlateletsBlood, 1997
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Anagrelide, a therapy for thrombocythemic states: Experience in 577 patientsThe American Journal of Medicine, 1992
- Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosomeAmerican Journal of Hematology, 1988